Physician profile
David E Ruggieri
NPI 1891702965
$1,445.52
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $836 · 2020: $138 · 2021: $221 · 2022: $169 · 2023: $18.43 · 2024: $63.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $81.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $81.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $781.67 | 2019 | |
| Biotronik INC. | $402.82 | 2020-2024 | Biomonitor, Renamic Neo |
| Venclose INC. | $98.38 | 2020 | |
| Novo Nordisk INC | $48.75 | 2021-2022 | |
| Astellas Pharma US INC | $42.64 | 2019 | |
| Cvrx, INC. | $23.49 | 2024 | Barostim Neo System |
| Boston Scientific Corporation | $18.43 | 2023 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.31 | 2022 | |
| Glaxosmithkline, LLC. | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ruggieri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.